Intrauterine devices and intrauterine systems
- PMID:18400840
- DOI: 10.1093/humupd/dmn003
Intrauterine devices and intrauterine systems
Abstract
From a public health viewpoint, the intrauterine device (IUD) is the most widely used contraceptive method in the world. Prevalence rates range among countries from 2 to 80% of contraceptive users. During 5 years of IUD use, pregnancy occurs in less than 2 per 100 insertions. Bleeding and pain are the most common reasons for removal rates of 10% in the first year and up to 50% within 5 years. The contraceptive effects of IUDs may be due to a sterile inflammatory reaction in the endometrial cavity which interferes with sperm function, so that fertilization is less likely to occur. IUDs also interfere with implantation but the extent to which this contributes to their contraceptive action is unknown. In nulliparous women rates of expulsion and removal for bleeding and/or pain are higher than in parous women. Effective use of IUDs for up to 10 years has the same pregnancy rate as tubal interruption. Thus, the IUD may be an alternative to female sterilization, especially in younger women who are more likely to experience regret after sterilization. The levonorgestrel intrauterine system (LNG-IUS) reduces bleeding and dysmenorrhoea, provides superior effectiveness to copper IUDs, and may be a useful treatment for endometriosis or an alternative to hysterectomy for menorrhagia.
Similar articles
- Intrauterine devices. The optimal long-term contraceptive method?Fortney JA, Feldblum PJ, Raymond EG.Fortney JA, et al.J Reprod Med. 1999 Mar;44(3):269-74.J Reprod Med. 1999.PMID:10202746Review.
- Intrauterine devices: an effective alternative to oral hormonal contraception.[No authors listed][No authors listed]Prescrire Int. 2009 Jun;18(101):125-30.Prescrire Int. 2009.PMID:19637436
- Treatment of menorrhagia with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study.Wildemeersch D, Schacht E.Wildemeersch D, et al.Eur J Contracept Reprod Health Care. 2001 Jun;6(2):93-101.Eur J Contracept Reprod Health Care. 2001.PMID:11518454
- Selection and performance of the levonorgestrel-releasing intrauterine system.Lähteenmäki P, Bardin CW, Elomaa K, Haukkamaa M, Kivijärvi A, Kuukankorpi A, Venhola M, Tuominen J.Lähteenmäki P, et al.Acta Obstet Gynecol Scand Suppl. 1997;164:69-74.Acta Obstet Gynecol Scand Suppl. 1997.PMID:9225643
- Intrauterine steroid contraceptives.Scholten PC, Christaens GC, Haspels AA.Scholten PC, et al.Wien Med Wochenschr. 1987 Nov 15;137(20-21):479-83.Wien Med Wochenschr. 1987.PMID:3131966Review.
Cited by
- Comparing the effectiveness of copper intrauterine devices available in Canada. Is FlexiT non-inferior to NovaT when inserted immediately after first-trimester abortion? Study protocol for a randomized controlled trial.Norman WV, Chiles JL, Turner CA, Brant R, Aslan A, Kaczorowski J.Norman WV, et al.Trials. 2012 Aug 24;13:147. doi: 10.1186/1745-6215-13-147.Trials. 2012.PMID:22920273Free PMC article.Clinical Trial.
- Major depression associated with a levonorgestrel-releasing intrauterine system mimicking frontotemporal dementia: a case report.Valencia-Cifuentes V, Cañas CA, Rivas JC.Valencia-Cifuentes V, et al.Front Psychiatry. 2023 Sep 13;14:1266419. doi: 10.3389/fpsyt.2023.1266419. eCollection 2023.Front Psychiatry. 2023.PMID:37779626Free PMC article.
- A Novel Intrauterine Device for the Spatio-Temporal Release of Norethindrone Acetate as a Counter-Estrogenic Intervention in the Genitourinary Syndrome of Menopause.Abdelgader A, Govender M, Kumar P, Choonara YE.Abdelgader A, et al.Pharmaceutics. 2024 Apr 26;16(5):587. doi: 10.3390/pharmaceutics16050587.Pharmaceutics. 2024.PMID:38794250Free PMC article.
- A comparative study on attitude of contraceptive methods users towards common contraceptive methods.Ehsanpour S, Mohammadifard M, Shahidi S, Nekouyi NS.Ehsanpour S, et al.Iran J Nurs Midwifery Res. 2010 Dec;15(Suppl 1):363-70.Iran J Nurs Midwifery Res. 2010.PMID:22069412Free PMC article.
- A Dedicated Postpartum Intrauterine Device Inserter: Pilot Experience and Proof of Concept.Singh S, Das V, Agarwal A, Dewan R, Mittal P, Bhamrah R, Lerma K, Blumenthal PD.Singh S, et al.Glob Health Sci Pract. 2016 Mar 25;4(1):132-40. doi: 10.9745/GHSP-D-15-00355. Print 2016 Mar.Glob Health Sci Pract. 2016.PMID:27016549Free PMC article.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources